Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 487/04 (2006.01) A61K 31/495 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2555345

In its many embodiments, the present invention provides pyrazolo[1,5- a]pyrimidine compounds as inhibitors of cyclin dependent kinases, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with the CDKs using such compounds or pharmaceutical compositions.

Dans un bon nombre de modes de réalisation, on prévoit une nouvelle classe de composés pyrazolo[1,5-a]pyrimidine tenant lieu d'inhibiteurs de kinase dépendant de la cycline, des procédés de tels composés, de compositions pharmaceutiques contenant un ou plusieurs composés, de procédés de préparations de formulations pharmaceutiques comprenant un ou plusieurs des composés et des méthodes de traitement, de prévention, d'inhibition ou d'amélioration d'une ou plusieurs maladies associées aux CDK utilisant de tels composés ou compositions pharmaceutiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1919837

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.